ATE87625T1 - Gegebenenfalls etherifizierte oder esterifizierte in stellung 2 substituierte 4-oh- chinolincarbonsaeurederivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen. - Google Patents
Gegebenenfalls etherifizierte oder esterifizierte in stellung 2 substituierte 4-oh- chinolincarbonsaeurederivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.Info
- Publication number
- ATE87625T1 ATE87625T1 AT86401661T AT86401661T ATE87625T1 AT E87625 T1 ATE87625 T1 AT E87625T1 AT 86401661 T AT86401661 T AT 86401661T AT 86401661 T AT86401661 T AT 86401661T AT E87625 T1 ATE87625 T1 AT E87625T1
- Authority
- AT
- Austria
- Prior art keywords
- etherified
- esterified
- optional
- manufacture
- processes
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 239000013067 intermediate product Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- -1 -SCF3 Chemical group 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
- C07D265/22—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8511389A FR2585356B1 (fr) | 1985-07-25 | 1985-07-25 | Nouveaux derives de l'acide 4-oh quinoleine carboxylique substitues en 2 par deux fonctions hydroxyle eventuellement etherifiees ou esterifiees, leurs procedes de preparation, les nouveaux intermediaires obtenus, leur application comme medicaments et les compositions les renfermant |
| EP86401661A EP0214004B1 (de) | 1985-07-25 | 1986-07-24 | Gegebenenfalls etherifizierte oder esterifizierte in Stellung 2 substituierte 4-OH-Chinolincarbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Anwendung als Arzneimittel und diese enthaltende Zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE87625T1 true ATE87625T1 (de) | 1993-04-15 |
Family
ID=9321642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86401661T ATE87625T1 (de) | 1985-07-25 | 1986-07-24 | Gegebenenfalls etherifizierte oder esterifizierte in stellung 2 substituierte 4-oh- chinolincarbonsaeurederivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0214004B1 (de) |
| JP (1) | JPH0710863B2 (de) |
| KR (1) | KR940003759B1 (de) |
| AT (1) | ATE87625T1 (de) |
| AU (1) | AU609377B2 (de) |
| CA (1) | CA1262903A (de) |
| DE (1) | DE3688161T2 (de) |
| DK (1) | DK172034B1 (de) |
| ES (1) | ES2000739A6 (de) |
| FI (1) | FI86426C (de) |
| FR (1) | FR2585356B1 (de) |
| GR (1) | GR861924B (de) |
| HU (1) | HU202526B (de) |
| PT (1) | PT83064B (de) |
| SU (1) | SU1584749A3 (de) |
| ZA (1) | ZA865260B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4845105A (en) * | 1984-10-30 | 1989-07-04 | Roussel Uclaf | 4-OH-quinoline carboxylic acid amides having analgesic and anti-inflammatory activity |
| US5438344A (en) * | 1990-11-05 | 1995-08-01 | Oliva; Anthony | Portable video book |
| GB9108547D0 (en) * | 1991-04-22 | 1991-06-05 | Fujisawa Pharmaceutical Co | Quinoline derivatives |
| AU3339797A (en) * | 1996-06-20 | 1998-01-07 | Smithkline Beecham Plc | 4h-3,1-benzoxazin-4-one derivatives and analogs as antiviral agents |
| JP3337992B2 (ja) * | 1997-11-04 | 2002-10-28 | ファイザー製薬株式会社 | ５−置換ピコリン酸化合物及びその製造方法 |
| JP4804590B1 (ja) | 2010-04-14 | 2011-11-02 | 帝人テクノプロダクツ株式会社 | メタ型全芳香族ポリアミド繊維 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2509728A1 (fr) * | 1981-07-17 | 1983-01-21 | Roussel Uclaf | Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant |
| FR2530633A1 (fr) * | 1982-06-03 | 1984-01-27 | Roussel Uclaf | Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, et les compositions les renfermant |
| FR2566405B1 (fr) * | 1984-06-25 | 1986-09-26 | Roussel Uclaf | Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus |
| ZA871658B (en) * | 1986-03-27 | 1987-08-28 | Warner-Lambert Company | Chewing gum and confectionery compositions containing a soy flavor enhancer |
-
1985
- 1985-07-25 FR FR8511389A patent/FR2585356B1/fr not_active Expired
-
1986
- 1986-07-08 HU HU862842A patent/HU202526B/hu not_active IP Right Cessation
- 1986-07-15 ZA ZA865260A patent/ZA865260B/xx unknown
- 1986-07-22 JP JP61170961A patent/JPH0710863B2/ja not_active Expired - Fee Related
- 1986-07-23 SU SU864027833A patent/SU1584749A3/ru active
- 1986-07-23 GR GR861924A patent/GR861924B/el unknown
- 1986-07-24 DK DK351886A patent/DK172034B1/da not_active IP Right Cessation
- 1986-07-24 CA CA000514629A patent/CA1262903A/fr not_active Expired
- 1986-07-24 EP EP86401661A patent/EP0214004B1/de not_active Expired - Lifetime
- 1986-07-24 AT AT86401661T patent/ATE87625T1/de not_active IP Right Cessation
- 1986-07-24 DE DE86401661T patent/DE3688161T2/de not_active Expired - Fee Related
- 1986-07-24 FI FI863040A patent/FI86426C/fi not_active IP Right Cessation
- 1986-07-24 AU AU60509/86A patent/AU609377B2/en not_active Ceased
- 1986-07-24 KR KR1019860006045A patent/KR940003759B1/ko not_active Expired - Fee Related
- 1986-07-24 ES ES8600554A patent/ES2000739A6/es not_active Expired
- 1986-07-25 PT PT83064A patent/PT83064B/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0214004A3 (en) | 1989-04-05 |
| DE3688161D1 (de) | 1993-05-06 |
| ES2000739A6 (es) | 1988-03-16 |
| HU202526B (en) | 1991-03-28 |
| KR940003759B1 (ko) | 1994-04-30 |
| FI86426C (fi) | 1992-08-25 |
| JPH0710863B2 (ja) | 1995-02-08 |
| FI863040A0 (fi) | 1986-07-24 |
| KR870001206A (ko) | 1987-03-12 |
| FI86426B (fi) | 1992-05-15 |
| SU1584749A3 (ru) | 1990-08-07 |
| AU6050986A (en) | 1987-01-29 |
| FR2585356B1 (fr) | 1987-10-23 |
| DK351886D0 (da) | 1986-07-24 |
| EP0214004A2 (de) | 1987-03-11 |
| JPS6229585A (ja) | 1987-02-07 |
| ZA865260B (en) | 1987-09-30 |
| GR861924B (en) | 1986-11-25 |
| EP0214004B1 (de) | 1993-03-31 |
| DK351886A (da) | 1987-01-26 |
| DE3688161T2 (de) | 1993-10-14 |
| FR2585356A1 (fr) | 1987-01-30 |
| PT83064A (en) | 1986-08-01 |
| AU609377B2 (en) | 1991-05-02 |
| DK172034B1 (da) | 1997-09-22 |
| FI863040A7 (fi) | 1987-01-26 |
| CA1262903A (fr) | 1989-11-14 |
| PT83064B (pt) | 1989-02-28 |
| HUT43598A (en) | 1987-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE9793T1 (de) | 5-oxo- und 5-thioxoproline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| DK159148C (da) | Analogifremgangsmaade til fremstilling af tranexamsyrederivater | |
| ATE224T1 (de) | 1,2-dihydro-chinolin-2-on-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel. | |
| AT384424B (de) | Verfahren zur herstellung von neuen 3-hydroxy-2-oxo-pyrrolidinderivaten und ihren salzen | |
| DE3670081D1 (de) | Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen. | |
| DE3678797D1 (de) | Neue 3-oxadiazol- und 3-carbonsaeure-beta-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel. | |
| ATE18549T1 (de) | 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung. | |
| DE3688161D1 (de) | Gegebenenfalls etherifizierte oder esterifizierte in stellung 2 substituierte 4-oh-chinolincarbonsaeurederivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen. | |
| ATE30725T1 (de) | Heterocyclische phenylaether, verfahren zu deren herstellung und diese enthaltende herbizide mittel. | |
| ES2016017A6 (es) | Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico. | |
| DE69130266D1 (de) | Optisch wirksame Alkylendioxybenzolderivate und ihre Verwendung als Arzneimittel | |
| ATE18667T1 (de) | Aethenylimidazol-derivate, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen, bei deren herstellung verwendbare zwischenprodukte und verfahren zu deren herstellung. | |
| ATE46147T1 (de) | 4-(nitrophenyl)-tetrahydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| DE3884319D1 (de) | Imidazobenzodiazepine und ihre Säureadditionssalze, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende Zubereitungen. | |
| ES8500923A1 (es) | Procedimiento para la preparacion de derivados de acido fenilacetico | |
| ATE19879T1 (de) | Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| FI102280B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 2-formyylibentsyylifosfonihappojohdannaisten valmistamiseksi | |
| DE58906619D1 (de) | Neue Leukotrien-B4-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel. | |
| ES8801264A1 (es) | Procedimiento para la obtencion de derivados de piridazo(1,2-a)(1,2)diacepina | |
| ATE48424T1 (de) | Esterderivate von 2-alpha-hydroxy-substituierter 4-hydroxy-3-chinolincarbonsaeure, ihre herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen. | |
| ATE33493T1 (de) | Phenylethylaminopropiophenon-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| ATE1585T1 (de) | Clavulansaeurederivate, ihre herstellung und sie enthaltende pharmazeutische praeparate. | |
| ATE2075T1 (de) | Oxazolin- und thiazolin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| ATE28646T1 (de) | Imidazo(1,2-a)chinoline, ihre salze, ihre herstellung und verwendung als arzneimittel und diese enthaltende zubereitungen. | |
| DE3784883D1 (de) | Fluor enthaltende makrolid-verbindungen, pharmazeutische zusammensetzungen, welche diese enthalten und ihre verwendung fuer die herstellung von arzneimitteln. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |